These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7393042)

  • 1. Survey of cardiac failure therapy in Australian medical practice: dependence on digoxin level for diagnosis of toxicity.
    Schapel GJ; Read TR
    Med J Aust; 1980 May; 1(11):549-50. PubMed ID: 7393042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of combined treatment in chronic congestive heart failure with digoxin, furosemide and pentoxifylline upon blood viscosity].
    Kochmański M; Zochowski RJ
    Pol Arch Med Wewn; 1990 Nov; 84(5):309-20. PubMed ID: 2075124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure.
    Hutcheon D; Nemeth E; Quinlan D
    J Clin Pharmacol; 1980 Jan; 20(1):59-68. PubMed ID: 7358869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical management of congestive heart failure in a horse.
    Brumbaugh GW; Thomas WP; Hodge TG
    J Am Vet Med Assoc; 1982 Apr; 180(8):878-83. PubMed ID: 7085465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
    Adigun AQ; Ajayi AA
    Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma digoxin concentration in children with heart failure.
    Cree JE; Coltart DJ; Howard MR
    Br Med J; 1973 Feb; 1(5851):443-4. PubMed ID: 4689830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to digitalize and to maintain optimal digoxin levels in congestive heart failure.
    Lambert C; Rouleau JL
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):717-26. PubMed ID: 2488083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum digoxin levels in elderly nursing home patients: appraisal of routine periodic measurements.
    Dimant J; Merrit W
    J Am Geriatr Soc; 1978 Aug; 26(8):378-9. PubMed ID: 670627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of digoxin administered to horses with congestive heart failure.
    Sweeney RW; Reef VB; Reimer JM
    Am J Vet Res; 1993 Jul; 54(7):1108-11. PubMed ID: 8368606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of pharmacokinetics and dosage in digoxin maintenance therapy. A retrospective analysis of serum digoxin levels.
    Joubert PH; Müller FO; Pansegrouw DF
    S Afr Med J; 1974 May; 48(21):907-9. PubMed ID: 4834608
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical value of digoxin in patients with heart failure and sinus rhythm.
    McHaffie D; Purcell H; Mitchell-Heggs P; Guz A
    Q J Med; 1978 Oct; 47(188):401-19. PubMed ID: 751085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques for studying the pharmacodynamic effects of cardiac glycosides on patients' own erythrocytes during glycoside therapy.
    Aronson JK; Ford AR; Grahame-Smith DG
    Klin Wochenschr; 1981 Dec; 59(24):1323-32. PubMed ID: 6275162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical therapy of cardiac insufficiency in the initial stage of myocardial infarct].
    Schweiser W
    Arch Mal Coeur Vaiss; 1973 Apr; 66(4):409-15. PubMed ID: 4198843
    [No Abstract]   [Full Text] [Related]  

  • 15. [An increase in plasma digoxin levels after discontinuation of therapy].
    Duraković Z; Plavsić F; Kuzmanić D
    Lijec Vjesn; 1991; 113(3-4):79-80. PubMed ID: 1890921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of digoxin, furosemide and finoptin on the central hemodynamics in hypertension].
    Orynchak Ma
    Vrach Delo; 1989 Mar; (3):35-8. PubMed ID: 2750115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of body weight in treatment with digoxin and digoxin derivatives (author's transl)].
    Schneider J; Ruiz-Torres A
    Dtsch Med Wochenschr; 1977 Jan; 102(4):116-8. PubMed ID: 832590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of treatment for severe congestive heart failure with digoxin, furosemide and vasodilating agents].
    Markiewicz K; Cholewa M; Górski L; Gawor Z; Dryjański T; Kaczkowska-Marusik E; Bubiński R
    Pol Arch Med Wewn; 1990 Aug; 84(2):86-97. PubMed ID: 2277787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension].
    Orynchak MA
    Ter Arkh; 1989; 61(8):17-21. PubMed ID: 2686070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
    Brouwer J; van Veldhuisen DJ; Man in 't Veld AJ; Dunselman PH; Boomsma F; Haaksma J; Lie KI
    J Am Coll Cardiol; 1995 Oct; 26(4):983-90. PubMed ID: 7560628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.